Código QR

Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.

Treatment with the combination of aspirin and dipyridamole is believed to reduce the incidence of coronary vein graft occlusion. A double blind randomised controlled trial was carried out in which aspirin 990 mg and dipyridamole 225 mg daily or placebo were added to the routine postoperative managem...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br Heart J
Principais autores: Brooks, N, Wright, J, Sturridge, M, Pepper, J, Magee, P, Walesby, R, Layton, C, Honey, M, Balcon, R
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 1985
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481740/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3881108/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.2.201
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!